Cancer BiologybioRxivPreprint
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma
A. K. Weiner, A. B. Radaoui, M. Tsang…·S. J. Diskin
This study identifies DLK1 as a potential immunotherapeutic target in neuroblastoma through integrative proteomic, transcriptomic, and epigenomic analysis.
DOI 10.1101/2023.12.06.570390